mRNA Cleavage and Polyadenylation Factors
"mRNA Cleavage and Polyadenylation Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Factors that are involved in directing the cleavage and POLYADENYLATION of the of MESSENGER RNA near the site of the RNA 3' POLYADENYLATION SIGNALS.
| Descriptor ID |
D039221
|
| MeSH Number(s) |
D12.776.157.725.124 D12.776.664.962.444
|
| Concept/Terms |
Polyadenylation Factors- Polyadenylation Factors
- Pre-mRNA Polyadenylation Factor
- Polyadenylation Factor, Pre-mRNA
- Pre mRNA Polyadenylation Factor
- Polyadenylation Factor
|
Below are MeSH descriptors whose meaning is more general than "mRNA Cleavage and Polyadenylation Factors".
Below are MeSH descriptors whose meaning is more specific than "mRNA Cleavage and Polyadenylation Factors".
This graph shows the total number of publications written about "mRNA Cleavage and Polyadenylation Factors" by people in this website by year, and whether "mRNA Cleavage and Polyadenylation Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "mRNA Cleavage and Polyadenylation Factors" by people in Profiles.
-
Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites. Sci Adv. 2023 02 17; 9(7):eade4814.
-
Estrogen promotes increased breast cancer cell proliferation and migration through downregulation of CPEB1 expression. Biochem Biophys Res Commun. 2021 01 01; 534:871-876.
-
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
-
CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature. 2014 Jun 19; 510(7505):412-6.
-
Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia. J Hematol Oncol. 2014 Mar 27; 7:26.
-
Translational control mechanisms in long-lasting synaptic plasticity and memory. J Biol Chem. 2010 Oct 15; 285(42):31913-7.
-
Translational control of long-lasting synaptic plasticity and memory. Neuron. 2009 Jan 15; 61(1):10-26.
-
Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia. J Clin Oncol. 2008 Apr 20; 26(12):2040-1.
-
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1. Leukemia. 2007 Jul; 21(7):1395-404.
-
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells. Leuk Res. 2006 Dec; 30(12):1499-505.